MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Assessing the Predictive Accuracy of Baseline Neuropsychiatric and Axial Motor Features for Freezing of Gait in Parkinson’s Disease at 5-year Follow up: The PPMI Cohort

    J. Li, R. Rajmohan, J. Ruiz Tejeda, N. Phielipp (Irvine, USA)

    Objective: To determine if neuropsychiatric and axial motor symptoms at baseline would be predictive of freezing of gait (FoG) at 5-year follow up in participants…
  • 2024 International Congress

    Neuroprotective Action of Exogenous Melatonin in Parkinson Disease Patients and its Impact on Daily Routine: a Systematic Review

    G. Maia, P. Silva, M. Rosa, R. Albuquerque, E. Almeida, C. Menegon, V. Serafim, F. Oliveira, G. Sorato, I. Fink, C. Rieder (Porto Alegre, Brazil)

    Objective: This study aims to evaluate the neuroprotective action of exogenous melatonin in Parkinson disease patients and its impact on daily routine. Background: Parkinson Disease…
  • 2024 International Congress

    Effect of Diabetes Mellitus on the Phenotype of Parkinson’s Disease

    IH. Kwak, HI. Ma, YE. Kim, JJ. Lee (Anyang-si, Republic of Korea)

    Objective: In this study, we aim to investigate whether Type 2 diabetes (T2DM) influences the phenotype of Parkinson’s disease (PD). Background: In PD, T2DM may…
  • 2024 International Congress

    Proposed framework to evaluate the ability of digital measures to track early stage Parkinson’s disease progression

    S. Shin, K. Ho, C. Chen, S. Li, N. Kowahl, E. Rainaldi, L. Evers, M. Meinders, L. Shih, A. Siderowf, B. Bloem, R. Kapur (South San Francisco, USA)

    Objective: To introduce a technical framework for evaluating digital measures for their ability to track Parkinson’s disease (PD) progression and apply the framework to digital…
  • 2024 International Congress

    Territorial inventory of training needs in nursing home for the support of patients with Parkinson’s syndrome

    J. Thezenas (Eaubonne, France)

    Objective: - Raise awareness among the various professionals in contact with patients suffering from Parkinson's syndromes- Optimize follow-up and support- Avoid emergency room visits through…
  • 2024 International Congress

    Clinico-radiological Spectrum and Predictors of Disease Severity in Neurological Wilson Disease: A Single Center Observational Study.

    A. Ranjan, R. Solanki, N. Sinha (Patna, India)

    Objective: To determine the Clinical and radiological spectrum of neurological Wilson’s disease (WD) and predictors of disease severity. Background: Wilson’s Disease (WD) is autosomal recessive,…
  • 2024 International Congress

    Anosognosia for hardware-related complications in deep brain stimulation

    F. Wolff Fernandes, J. Runge, A. Saryyeva, JK. Krauss (Hannover, Germany)

    Objective: In this series, we report two rare cases of selective unawareness to hardware-related complications in deep brain stimulation (DBS). Background: DBS has shown good…
  • 2024 International Congress

    Neurophenomenological Aspects of Monocular Visual Hallucinations in Charles Bonnet Syndrome in a patient with Parkinson’s Disease

    D. Nolasco, A. Makarem, B. Buchowicz, L. Schmidt, B. Carr (Gainesville, USA)

    Objective: This inquiry aims to augment understanding of Charles Bonnet Syndrome (CBS) by scrutinizing both monocular and bilateral visual hallucinations. It focuses on an atypical…
  • 2024 International Congress

    Multifaceted Challenges in Multisystem Atrophy Management: Medication Sensitivity, Emotional Lability, and Increased Fall Risk

    G. Legerme, B. Carr, C. Rowan (Gainesville, USA)

    Objective: Multisystem atrophy (MSA) epitomizes a formidable quandary within neurological and geriatric disciplines, delineated by complex manifestations encompassing autonomic dysfunction, parkinsonism, and cerebellar ataxia. This…
  • 2024 International Congress

    Multiple System Atrophy in a Patient with Normal Pressure Hydrocephalus

    E. Hayden, M. Elkasaby, B. Appleby (Cleveland, USA)

    Objective: To review a case of a patient diagnosed with both NPH and MSA. Background: Multiple system atrophy (MSA) is a progressive neurodegenerative disease that…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley